The Application of Deep Brain Stimulation for Parkinson’s Disease on the Motor Pathway: A Bibliometric Analysis across 10 Years

Abstract

Background and Objective

Since its initial report by James Parkinson in 1817, Parkinson’s disease (PD) has remained a central subject of research and clinical advancement. The disease is estimated to affect approximately 1% of adults aged 60 and above. Deep brain stimulation, emerging as an alternative therapy for end-stage cases, has offered a lifeline to numerous patients. This review aimed to analyze publications pertaining to the impact of deep brain stimulation on the motor pathway in patients with PD over the last decade.

Methods

Data were obtained from the Web of Science Core Collection through the library of Huazhong University of Science and Technology (China). The search strategy encompassed the following keywords: “deep brain stimulation”, “Parkinson’s disease”, “motor pathway”, and “human”, from January 1, 2012, to December 1, 2022. Additionally, this review visualized the findings using the Citespace software.

Results

The results indicated that the United States, the United Kingdom, Germany, and China were the primary contributors to this research field. University College London, Capital Medical University, and Maastricht University were the top 3 research institutions in the research area. Tom Foltynie ranked first with 6 publications, and the journals of Brain and Brain Stimulation published the greatest number of relevant articles. The prevailing research focal points in this domain, as determined by keywords “burst analysis”, “encompassed neuronal activity”, “nucleus”, “hyper direct pathway”, etc.

Conclusion

This study has provided a new perspective through bibliometric analysis of the deep brain stimulation therapy for treating patients with PD, which can shed light on future research to advance our comprehension of this particular field of study.

Keywords

deep brain stimulation / Parkinson’s disease / motor pathway / bibliometric analysis

References

[1] SamiiA, NuttJG, RansomBR. Parkinson’s disease. Lancet, 2004, 363(9423): 1783-1793

[2] AscherioA, SchwarzschildMA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol, 2016, 15(12): 1257-1272

[3] SchneiderRB, IourinetsJ, RichardIH. Parkinson’s disease psychosis: presentation, diagnosis and management. Neurodegener Dis Manag, 2017, 7(6): 365-376

[4] ReichSG, SavittJM. Parkinson’s Disease. Med Clin North Am, 2019, 103(2): 337-350

[5] TolosaE, WenningG, PoeweW. The diagnosis of Parkinson’s disease. Lancet Neurol, 2006, 5(1): 75-86

[6] SchapiraAHV, ChaudhuriKR, JennerP. Non-motor features of Parkinson disease. Nat Rev Neurosci, 2017, 18(7): 435-450

[7] JankovicJ, ShererT. The future of research in Parkinson disease. JAMA Neurol, 2014, 71(11): 1351-1352

[8] Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol, 2017,16(11):877–897

[9] SharmaVD, PatelM, MiocinovicS. Surgical Treatment of Parkinson’s Disease: Devices and Lesion Approaches. Neurotherapeutics, 2020, 17(4): 1525-1538

[10] HayesMT. Parkinson’s Disease and Parkinsonism. Am J Med, 2019, 132(7): 802-807

[11] VijiaratnamN, SimuniT, BandmannO, et al.. Progress towards therapies for disease modification in Parkinson’s disease. Lancet Neurol, 2021, 20(7): 559-572

[12] LeesAJ, HardyJ, ReveszT. Parkinson’s disease. Lancet, 2009, 373(9680): 2055-2066

[13] ArmstrongMJ, OkunMS. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA, 2020, 323(6): 548-560

[14] Alves Da RochaP, McClellandJ, MorrisME. Complementary physical therapies for movement disorders in Parkinson’s disease: a systematic review. Eur J Phys Rehabil Med, 2015, 51(6): 693-704

[15] MakMK, Wong-YuIS, ShenX, et al.. Long-term effects of exercise and physical therapy in people with Parkinson disease. Nat Rev Neurol, 2017, 13(11): 689-703

[16] DayJO, MullinS. The Genetics of Parkinson’s Disease and Implications for Clinical Practice. Genes (Basel), 2021, 12(7): 1006

[17] SaranzaG, LangAE. Levodopa challenge test: indications, protocol, and guide. J Neurol, 2021, 268(9): 3135-3143

[18] SchuepbachWMM, TonderL, SchnitzlerA, et al.. Quality of life predicts outcome of deep brain stimulation in early Parkinson disease. Neurology, 2019, 92(10): e1109-e1120

[19] FereshtehnejadSM, PostumaRB. Subtypes of Parkinson’s Disease: What Do They Tell Us About Disease Progression?. Curr Neurol Neurosci Rep, 2017, 17(4): 34

[20] ChungSJ, YooHS, ShinNY, et al.. Perivascular Spaces in the Basal Ganglia and Long-term Motor Prognosis in Newly Diagnosed Parkinson Disease. Neurology, 2021, 96(16): e2121-e2131

[21] PajaresM, AIR, MandaG, et al.. Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications. Cells, 2020, 9(7): 1687

[22] KhanAU, AkramM, DaniyalM, et al.. Awareness and current knowledge of Parkinson’s disease: a neurodegenerative disorder. Int J Neurosci, 2019, 129(1): 55-93

[23] ArmstrongMJ, OkunMS. Choosing a Parkinson Disease Treatment. JAMA, 2020, 323(14): 1420

[24] GraysonM. Parkinson’s disease. Nature, 2010, 466(7310): S1

[25] EspayAJ, BrundinP, LangAE. Precision medicine for disease modification in Parkinson disease. Nat Rev Neurol, 2017, 13(2): 119-126

[26] ChenZ, LiG, LiuJ. Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis, 2020, 134: 104700

[27] FengYS, YangSD, TanZX, et al.. The benefits and mechanisms of exercise training for Parkinson’s disease. Life Sci, 2020, 245: 117345

[28] ClausI, MuhleP, CzechowskiJ, et al.. Expiratory Muscle Strength Training for Therapy of Pharyngeal Dysphagia in Parkinson’s Disease. Mov Disord, 2021, 36(8): 1815-1824

[29] HarizM. Twenty-five years of deep brain stimulation: celebrations and apprehensions. Mov Disord, 2012, 27(7): 930-933

[30] BenabidAL, PollakP, LouveauA, et al.. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol, 1987, 50(1–6): 344-346

[31] BronsteinJM, TagliatiM, AltermanRL, et al.. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol, 2011, 68(2): 165

[32] HabetsJGV, HeijmansM, KuijfML, et al.. An update on adaptive deep brain stimulation in Parkinson’s disease. Mov Disord, 2018, 33(12): 1834-1843

[33] JankovicJ, TanEK. Parkinson’s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry, 2020, 91(8): 795-808

[34] HarizM, BlomstedtP. Deep brain stimulation for Parkinson’s disease. J Intern Med, 2022, 292(5): 764-778

[35] Ramirez-ZamoraA, OstremJL. Globus Pallidus Interna or Subthalamic Nucleus Deep Brain Stimulation for Parkinson Disease: A Review. JAMA Neurol, 2018, 75(3): 367-372

[36] OkunMS. Deep-brain stimulation for Parkinson’s disease. N Engl J Med, 2012, 367(16): 1529-1538

[37] LimousinP, FoltynieT. Long-term outcomes of deep brain stimulation in Parkinson disease. Nat Rev Neurol, 2019, 15(4): 234-242

[38] KosutzkaZ, Rivaud-PechouxS, PougetP, et al.. Pathophysiology of gait disorders induced by bilateral globus pallidus interna stimulation in dystonia. Brain, 2020, 143(1): e3

[39] McGregorMM, NelsonAB. Circuit Mechanisms of Parkinson’s Disease. Neuron, 2019, 101(6): 1042-1056

[40] WalterBL, VitekJL. Surgical treatment for Parkinson’s disease. Lancet Neurol, 2004, 3(12): 719-728

[41] FoxSH, KatzenschlagerR, LimSY, et al.. International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson’s disease. Mov Disord, 2018, 33(8): 1248-1266

[42] KoganM, McGuireM, RileyJ. Deep Brain Stimulation for Parkinson Disease. Neurosurg Clin N Am, 2019, 30(2): 137-146

[43] PringsheimT, DayGS, SmithDB, et al.. Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee. Neurology, 2021, 97(20): 942-957

[44] DongJ, CuiY, LiS, et al.. Current Pharmaceutical Treatments and Alternative Therapies of Parkinson’s Disease. Curr Neuropharmacol, 2016, 14(4): 339-355

[45] de Almeida MarcelinoAL, HornA, KrauseP, et al.. Subthalamic neuromodulation improves shortterm motor learning in Parkinson’s disease. Brain, 2019, 142(8): 2198-2206

[46] MansouriA, TaslimiS, BadhiwalaJH, et al.. Deep brain stimulation for Parkinson’s disease: meta-analysis of results of randomized trials at varying lengths of follow-up. J Neurosurg, 2018, 128(4): 1199-1213

[47] KaliaSK, SankarT, LozanoAM. Deep brain stimulation for Parkinson’s disease and other movement disorders. Curr Opin Neurol, 2013, 26(4): 374-380

[48] JakobsM, LeeDJ, LozanoAM. Modifying the progression of Alzheimer’s and Parkinson’s disease with deep brain stimulation. Neuropharmacology, 2020, 171: 107860

[49] HolewijnRA, VerbaanD, van den MunckhofPM, et al.. General Anesthesia vs Local Anesthesia in Microelectrode Recording-Guided Deep-Brain Stimulation for Parkinson Disease: The GALAXY Randomized Clinical Trial. JAMA Neurol, 2021, 78(10): 1212-1219

[50] MostofiA, MorganteF, EdwardsMJ, et al.. Pain in Parkinson’s disease and the role of the subthalamic nucleus. Brain, 2021, 144(5): 1342-1350

[51] LeeLN, HuangCS, ChuangHH, et al.. An electrophysiological perspective on Parkinson’s disease: symptomatic pathogenesis and therapeutic approaches. J Biomed Sci, 2021, 28(1): 85

[52] ZhaoJ, ZhuJ, HuangC, et al.. Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis. Front Immunol, 2022, 13: 1035151

[53] XiaD, YaoR, WangS, et al.. Mapping Trends and Hotspots Regarding Clinical Research on COVID-19: A Bibliometric Analysis of Global Research. Front Public Health, 2021, 9: 713487

[54] XiM, GaoX. Bibliometric Analysis of Research Relating to IgA Nephropathy from 2010 to 2021. Med Sci Monit, 2022, 28: e937976

[55] YuanG, ShiJ, JiaQ, et al.. Cardiac Rehabilitation: A Bibliometric Review From 2001 to 2020. Front Cardiovasc Med, 2021, 8: 672913

[56] AhmadT, OrnosEDB, AhmadS, et al.. Global Research Mapping of Psycho-Oncology Between 1980 and 2021: A Bibliometric Analysis. Front Psychol, 2022, 13: 947669

[57] ZhangX, CaiJ, ChenL, et al.. Mapping global trends in research of stem cell therapy for COVID-19: A bibliometric analysis. Front Public Health, 2022, 10: 1016237

[58] LiR, SunJ, HuH, et al.. Research Trends of Acupuncture Therapy on Knee Osteoarthritis from 2010 to 2019: A Bibliometric Analysis. J Pain Res, 2020, 13: 1901-1913

[59] ChenC. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A, 2004, 101(Suppl 1): 5303-5310 Suppl 1

[60] ZhouQ, KongHB, HeBM, et al.. Bibliometric Analysis of Bronchopulmonary Dysplasia in Extremely Premature Infants in the Web of Science Database Using CiteSpace Software. Front Pediatr, 2021, 9: 705033

[61] de HemptinneC, SwannNC, OstremJL, et al.. Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson’s disease. Nat Neurosci, 2015, 18(5): 779-786

[62] CavanaghJF, WieckiTV, CohenMX, et al.. Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nat Neurosci, 2011, 14(11): 1462-1467

[63] XuD, WangYL, WangKT, et al.. A Scientometrics Analysis and Visualization of Depressive Disorder. Curr Neuropharmacol, 2021, 19(6): 766-786

[64] LuoH, CaiZ, HuangY, et al.. Study on Pain Catastrophizing From 2010 to 2020: A Bibliometric Analysis via CiteSpace. Front Psychol, 2021, 12: 759347

[65] MiaoL, ZhangJ, ZhangZ, et al.. A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021. Front Immunol, 2022, 13: 840956

[66] HuangX, FanX, YingJ, et al.. Emerging trends and research foci in gastrointestinal microbiome. J Transl Med, 2019, 17(1): 67

[67] DingH, WuC, LiaoN, et al.. Radiomics in Oncology: A 10-Year Bibliometric Analysis. Front Oncol, 2021, 11: 689802

[68] SunHL, BaiW, LiXH, et al.. Schizophrenia and Inflammation Research: A Bibliometric Analysis. Front Immunol, 2022, 13: 907851

[69] LiuS, SunYP, GaoXL, et al.. Knowledge domain and emerging trends in Alzheimer’s disease: a scientometric review based on CiteSpace analysis. Neural Regen Res, 2019, 14(9): 1643-1650

[70] ZhongD, LiY, HuangY, et al.. Molecular Mechanisms of Exercise on Cancer: A Bibliometrics Study and Visualization Analysis via CiteSpace. Front Mol Biosci, 2021, 8: 797902

[71] DangQ, LuoZ, OuyangC, et al.. First Systematic Review on Health Communication Using the CiteSpace Software in China: Exploring Its Research Hotspots and Frontiers. Int J Environ Res Public Health, 2021, 18(24): 13008

[72] BrabenecL, KlobusiakovaP, SimkoP, et al.. Noninvasive brain stimulation for speech in Parkinson’s disease: A randomized controlled trial. Brain Stimul, 2021, 14(3): 571-578

[73] ChungCL, MakMK. Effect of Repetitive Transcranial Magnetic Stimulation on Physical Function and Motor Signs in Parkinson’s Disease: A Systematic Review and Meta-Analysis. Brain Stimul, 2016, 9(4): 475-487

[74] ZanjaniA, ZakzanisKK, DaskalakisZJ, et al.. Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson’s disease: A quantitative review of the literature. Mov Disord, 2015, 30(6): 750-758

[75] LiR, HeY, QinW, et al.. Effects of Repetitive Transcranial Magnetic Stimulation on Motor Symptoms in Parkinson’s Disease: A Meta-Analysis. Neurorehabil Neural Repair, 2022, 36(7): 395-404

[76] ChungCL, MakMK, HallettM. Transcranial Magnetic Stimulation Promotes Gait Training in Parkinson Disease. Ann Neurol, 2020, 88(5): 933-945

[77] ChenR, UdupaK. Measurement and modulation of plasticity of the motor system in humans using transcranial magnetic stimulation. Motor Control, 2009, 13(4): 442-453

[78] TrungJ, HanganuA, JobertS, et al.. Transcranial magnetic stimulation improves cognition over time in Parkinson’s disease. Parkinsonism Relat Disord, 2019, 66: 3-8

[79] ChenKS, ChenR. Invasive and Noninvasive Brain Stimulation in Parkinson’s Disease: Clinical Effects and Future Perspectives. Clin Pharmacol Ther, 2019, 106(4): 763-775

[80] UdupaK, BahlN, NiZ, et al.. Cortical Plasticity Induction by Pairing Subthalamic Nucleus Deep-Brain Stimulation and Primary Motor Cortical Transcranial Magnetic Stimulation in Parkinson’s Disease. J Neurosci, 2016, 36(2): 396-404

[81] IlsonM, SampsonM, BarrowmanN, et al.. Bibliometric Analysis of Neurology Articles Published in General Medicine Journals. JAMA Netw Open, 2021, 4(4): e215840